CASI Pharmaceuticals Inc — Cash Flow (NASDAQ:CASI) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 21.09 M19.97 M29.2 M — Cash from investing activities 31.16 M9.67 M11.24 M — Cash from financing activities 3.27 M907 K15.43 M — Free cash flow 15.48 M17.73 M28.96 M —

Новости

What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

Рынок акций США закрылся ростом, Dow Jones прибавил 0,63%

Акции CASI Pharmaceuticals обвалились после уведомления о делистинге с NASDAQ

CASI Pharmaceuticals stock plunges on Nasdaq delisting notice

Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging Alkermes (ALKS) This Year?

China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection

Акции CASI Pharmaceuticals растут после продления листинга на NASDAQ

CASI Pharmaceuticals получает продление листинга на Nasdaq до февраля 2026

CASI Pharmaceuticals stock surges after Nasdaq grants listing extension

Casi Pharmaceuticals secures Nasdaq listing extension until February 2026